Bavarian Nordic A/S
Cancer vaccine developer establishes new operations in the U.S.
Published in Law and Health Weekly, January 22nd, 2005
Bavarian Nordic A/S sets up a holding company in the USA, Bavarian Nordic, Inc., which based in Delaware will serve as legal entity for future activities in the U.S.
Furthermore, Bavarian Nordic A/S establishes an operating company, BN ImmunoTherapeutics, Inc., for research and development of cancer vaccines, initially against breast, prostate and colon cancers. BN ImmunoTherapeutics will have its base in the Palo Alto area of California and scientific activities are expected to begin in January 2005.
Bavarian Nordic A/S will...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Law and Health Weekly
More Articles from Law and Health Weekly
- Array BioPharma, Inc.
InterMune granted expanded rights under hepatitis agreement - Children's Hospital of Pennsylvania
Informed consent assessment requires appreciation of patient's risk, motivation - Eyetech Pharmaceuticals, Inc.
U.S. FDA approves Macugen for treatment of neovascular wet AMD - Imperial College London
Tetanus vaccination with IL-2 during HAART induces sustained T-cell responses - Invacare Corp.
Medicare policies cause lowered share earnings - Legal Issues
Defense lawyers in steroid case seek to dismiss charges - More from this issue of Law and Health Weekly
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
